Reem Ali

626 total citations
32 papers, 463 citations indexed

About

Reem Ali is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Reem Ali has authored 32 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Reem Ali's work include DNA Repair Mechanisms (18 papers), PARP inhibition in cancer therapy (7 papers) and Cancer Genomics and Diagnostics (5 papers). Reem Ali is often cited by papers focused on DNA Repair Mechanisms (18 papers), PARP inhibition in cancer therapy (7 papers) and Cancer Genomics and Diagnostics (5 papers). Reem Ali collaborates with scholars based in United Kingdom, Qatar and United States. Reem Ali's co-authors include Srinivasan Madhusudan, Emad A. Rakha, Andrew R. Green, Helen E. Bryant, Islam M. Miligy, Mustapha Aouida, Dindial Ramotar, Michael S. Toss, Stephen Chan and Ian O. Ellis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

In The Last Decade

Reem Ali

29 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reem Ali United Kingdom 15 311 256 111 78 58 32 463
Sylaja Murikipudi United States 6 225 0.7× 238 0.9× 95 0.9× 61 0.8× 34 0.6× 8 470
Sara G. Manore United States 9 313 1.0× 256 1.0× 126 1.1× 70 0.9× 82 1.4× 13 579
Eddie Reed United States 12 349 1.1× 191 0.7× 84 0.8× 70 0.9× 54 0.9× 16 453
Grace L. Wong United States 9 341 1.1× 229 0.9× 150 1.4× 74 0.9× 77 1.3× 13 578
Chung‐Min Yeh Taiwan 13 310 1.0× 117 0.5× 134 1.2× 37 0.5× 42 0.7× 32 441
Patrycja Tudrej Poland 5 263 0.8× 185 0.7× 152 1.4× 48 0.6× 47 0.8× 8 544
Marco Mazzoletti Italy 9 413 1.3× 182 0.7× 97 0.9× 46 0.6× 45 0.8× 11 543
Chinnadurai Mani United States 14 363 1.2× 225 0.9× 80 0.7× 29 0.4× 45 0.8× 31 474
Marie Villedieu France 10 416 1.3× 151 0.6× 195 1.8× 61 0.8× 44 0.8× 10 531

Countries citing papers authored by Reem Ali

Since Specialization
Citations

This map shows the geographic impact of Reem Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reem Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reem Ali more than expected).

Fields of papers citing papers by Reem Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reem Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reem Ali. The network helps show where Reem Ali may publish in the future.

Co-authorship network of co-authors of Reem Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Reem Ali. A scholar is included among the top collaborators of Reem Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reem Ali. Reem Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ali, Reem, Alison Ritchie, Katia A. Mesquita, et al.. (2023). Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade. International Journal of Molecular Sciences. 24(13). 10966–10966. 2 indexed citations
5.
Ali, Reem, Bushra Memon, Mustapha Aouida, et al.. (2023). Altered Regulation of the Glucose Transporter GLUT3 in PRDX1 Null Cells Caused Hypersensitivity to Arsenite. Cells. 12(23). 2682–2682. 4 indexed citations
6.
Glaire, Mark A., Neil Ryan, Marieke E. Ijsselsteijn, et al.. (2022). Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape. The Journal of Pathology. 257(3). 340–351. 16 indexed citations
7.
Ali, Reem, et al.. (2022). The histone H2B Arg95 residue links the pheromone response pathway to rapamycin-induced G1 arrest in yeast. Scientific Reports. 12(1). 10023–10023. 2 indexed citations
8.
Aouida, Mustapha, et al.. (2022). C. elegans ribosomal protein S3 protects against H2O2-induced DNA damage and suppresses spontaneous mutations in yeast. DNA repair. 117. 103359–103359. 1 indexed citations
9.
Ali, Reem, Michael S. Toss, Natalie J. Tatum, et al.. (2022). Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers. npj Precision Oncology. 6(1). 51–51. 15 indexed citations
10.
Ali, Reem, Islam M. Miligy, Mansour Alsaleem, et al.. (2021). Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers. Oncogene. 40(14). 2496–2508. 21 indexed citations
11.
Ali, Reem, Islam M. Miligy, Katia A. Mesquita, et al.. (2021). Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers. Theranostics. 11(17). 8350–8361. 14 indexed citations
12.
Ali, Reem, Michael S. Toss, Islam M. Miligy, et al.. (2021). The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS). Breast Cancer Research and Treatment. 190(1). 39–51. 1 indexed citations
13.
14.
Ali, Reem, Islam M. Miligy, Katia A. Mesquita, et al.. (2019). PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers. Cancer Letters. 469. 124–133. 27 indexed citations
15.
Ali, Reem, Michael S. Toss, Andrew R. Green, et al.. (2018). Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention. Cancer Research. 78(24). 6818–6827. 29 indexed citations
16.
Alsubhi, Nouf H., Reem Ali, Tarek M.A. Abdel-Fatah, et al.. (2018). Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy. Breast Cancer Research and Treatment. 169(2). 277–286. 23 indexed citations
17.
Green, Andrew R., Mohammed A. Aleskandarany, Reem Ali, et al.. (2017). Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers. Cancer Immunology Research. 5(4). 292–299. 53 indexed citations
18.
Arora, Arvind, Swetha Parvathaneni, Mohammed A. Aleskandarany, et al.. (2016). Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers. Molecular Cancer Therapeutics. 16(1). 239–250. 15 indexed citations
19.
Ali, Reem, Emad A. Rakha, Srinivasan Madhusudan, & Helen E. Bryant. (2016). DNA damage repair in breast cancer and its therapeutic implications. Pathology. 49(2). 156–165. 54 indexed citations
20.
Ali, Reem, et al.. (2012). Breast cancer: Clinical stage at the time of presentation, its correlates and quality of life after treatment. 1(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026